A novel platform to enable inhaled naked RNAi medicine for lung cancer.

Home > 研究業績 > 原著論文 > A novel platform to enable inhaled naked RNAi medicine for lung cancer.

Sci Rep. 2013 Nov 25;3:3325.

Fujita Y, Takeshita F, Mizutani T, Ohgi T, Kuwano K, Ochiya T.

RNAi Therapeutic Platforms for Lung Diseases.

Exploratory analysis to predict pneumonitis during durvalumab consolidation therapy for patients with locally advanced non-small cell lung cancer from proteomic profiling of circulating extracellular vesicles

前のページに戻る